BioCentury
ARTICLE | Company News

HGSI, MEDX antibody deal

July 25, 2001 7:00 AM UTC

Human Genome Sciences and Medarex will use MEDX's UltiMAb technology to create human antibody leads specific to HGSI proteins. HGSI will have the option to license resulting therapeutic and diagnostic...